Business Description
Zenicor Medical Systems AB
ISIN : SE0006343984
Total Employee Number:
18Compare
Compare
Traded in other countries / regions
ZENI.Sweden IPO Date
2014-11-18Description
Zenicor Medical Systems AB is a medical technology company. It is engaged in remote diagnosis of cardiac care and stroke prevention.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | 1.51 | |||||
Interest Coverage | 1.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.73 | |||||
Beneish M-Score | -1.27 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -31.7 | |||||
3-Year EBITDA Growth Rate | 162.8 | |||||
3-Year FCF Growth Rate | 17.6 | |||||
3-Year Book Growth Rate | -5.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.45 | |||||
9-Day RSI | 44.5 | |||||
14-Day RSI | 45.5 | |||||
3-1 Month Momentum % | -8.49 | |||||
6-1 Month Momentum % | -19.17 | |||||
12-1 Month Momentum % | -60.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.43 | |||||
Quick Ratio | 2.13 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 1342.6 | |||||
Days Sales Outstanding | 14.56 | |||||
Days Payable | 896.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -59.9 | |||||
Shareholder Yield % | 7.63 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 96 | |||||
Operating Margin % | 10.4 | |||||
Net Margin % | 3.51 | |||||
EBITDA Margin % | 25.63 | |||||
FCF Margin % | -47.44 | |||||
OCF Margin % | -31.15 | |||||
ROE % | 2.04 | |||||
ROA % | 1.38 | |||||
ROIC % | 4.35 | |||||
3-Year ROIIC % | 10.93 | |||||
ROC (Joel Greenblatt) % | 79.11 | |||||
ROCE % | 5.3 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.68 | |||||
PE Ratio without NRI | 29.68 | |||||
PS Ratio | 0.7 | |||||
PB Ratio | 0.43 | |||||
Price-to-Tangible-Book | 1.18 | |||||
EV-to-EBIT | 11.64 | |||||
EV-to-EBITDA | 4.72 | |||||
EV-to-Revenue | 1.21 | |||||
EV-to-FCF | -2.55 | |||||
Price-to-GF-Value | 0.89 | |||||
Price-to-Median-PS-Value | 0.17 | |||||
Price-to-Graham-Number | 1.24 | |||||
| Price-to-Net-Current-Asset-Value | 1.44 | |||||
Earnings Yield (Greenblatt) % | 8.59 | |||||
FCF Yield % | -56.98 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zenicor Medical Systems AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 28.967 | ||
| EPS (TTM) (kr) | 0.031 | ||
| Beta | 0.335 | ||
| 3-Year Sharpe Ratio | -0.81 | ||
| 3-Year Sortino Ratio | -0.99 | ||
| Volatility % | 52.26 | ||
| 14-Day RSI | 45.5 | ||
| 14-Day ATR (kr) | 0.062647 | ||
| 20-Day SMA (kr) | 0.96625 | ||
| 12-1 Month Momentum % | -60.89 | ||
| 52-Week Range (kr) | 0.805 - 2.98 | ||
| Shares Outstanding (Mil) | 26.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zenicor Medical Systems AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zenicor Medical Systems AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-12 | In 153 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 48 days | ||
| Second quarter earnings results for 2026 | 2026-07-31 | 1.00 (+0.00%) | ||
| General meeting for 2026 | 2026-05-26 17:00 | 1.11 (-0.89%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 1.26 (+9.57%) | ||
| Annual report for 2025 | 2026-04-28 | 1.36 (-2.16%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-13 | 1.02 (+20.00%) | ||
| Third quarter earnings results for 2025 | 2025-10-27 | 1.49 (+2.05%) | ||
| Second quarter earnings results for 2025 | 2025-07-31 | 2.70 (+0.00%) | ||
| General meeting for 2025 | 2025-06-03 17:00 | 2.56 (+0.00%) |
Show
Entries
Zenicor Medical Systems AB Frequently Asked Questions
What is Zenicor Medical Systems AB(XSAT:ZENI)'s stock price today?
The current price of XSAT:ZENI is kr0.92. The 52 week high of XSAT:ZENI is kr2.98 and 52 week low is kr0.81.
When is next earnings date of Zenicor Medical Systems AB(XSAT:ZENI)?
The next earnings date of Zenicor Medical Systems AB(XSAT:ZENI) is 2026-10-30.
Does Zenicor Medical Systems AB(XSAT:ZENI) pay dividends? If so, how much?
Zenicor Medical Systems AB(XSAT:ZENI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers